As cited by the research report titled ‘Helicobacter Pylori Testing Market Size By Test Type, By Method (Point-of-care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Poland, Japan, Romania, Russia, China, India, Australia, South Korea, Brazil, Mexico, Chile, Argentina, South Africa, Saudi Arabia, Nigeria, Turkey), Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025’, available with Market Study Report,- global helicobacter pylori testing market is projected to accumulate USD 560 million over 2019-2025.
 

Growing geriatric populace, coupled with rising number of cases of infectious diseases are the major factors driving the global helicobacter pylori testing market growth. Increasing prevalence of gastric ulcer worldwide is resulting in growing adoption of non-invasive diagnostics solutions as H. pylori is mainly found in patients with gastric and duodenal ulcers.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2337488/
 

Additionally, advancements in technology and innovations in H. pylori infection testing are likely to accelerate the market growth. Numerous initiatives by various government organizations to control target disease and reduce the disease burden is augmenting the market outlook.
 

Furthermore, growing demand for diagnostics at comparably lower prices, benefits like rapid diagnosis along with availability of cost-effective testing kits are positively swaying the adoption of non-invasive methods, contributing to the overall market growth.
 

Based on test type, global helicobacter pylori testing industry share from serology test and urea breath test segments is poised to growth over 2019-2025. Serology test is a less expensive option to detect H. pylori infection and is mainly designed for testing large numbers, while UBT provides accurate results. UBT is free from sampling error as the whole stomach is involved and it detects current infection thus confirming eradication of H. pylori after treatment.
 

Speaking of end use range, the business space is fragmented into clinics, hospitals, and diagnostic laboratories. Considering method, the marketplace is categorized into point-of-care (POC) test, and laboratory-based test. Among these, point-of-care testing is slated to gain traction in the coming years, as it is less expensive and provides accurate results in less time.
 

Considering the regional framework, Middle East & Africa helicobacter pylori testing market size is poised to expand at 7.9% CAGR through the forecast timeline, owing to development in healthcare facilities, expanding infrastructure, and rising public expenditure on the disease treatment. Additionally, rising prevalence of cancer and peptic ulcers is anticipated to bolster the demand for diagnostics over the analysis duration. Moreover, increasing involvement of government to promote training of human resources available for H. pylori testing is positively swaying the industry dynamics.
 

Prominent players influencing the industry trends are Thermo Fisher Scientific Inc., Quidel Corporation, Meridian Bioscience Inc., Medline Industries Inc., Gulf Coast Scientific Inc., Exalenz Bioscience Ltd., Cardinal Health Inc., Bio-Rad Laboratories Inc., Biohit Oyj, Avanos Medical Inc., and Abbott Laboratories.